Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • toadear toadear Oct 7, 2013 12:15 PM Flag

    Short Interest will be announced 10/09 pm

    If there is a decline of 10-15% (which is what I expect) then SNTA will finish the week in the $6.60 - $6.75 range.

    If short interest declines by 15%, then a move into the $7.00 -$7.25 range.

    Where ever it ends up, expect a SLOW trend upward ($.05 per week) until more concrete news is announced. SNTA is certain to trade over $15.00 per share given positive, verifiable (no-spin) news. However, any negative news or setbacks in breast cancer drugs would be devastating - probably a 50% loss in share price.

    Current Market Cap is about $450MM. Institutions own 50% and they aren't budging until REAL news is available. Of the remaining shares, shorts now control about 1/3 of the float = REAL good news and they do face a squeeze, but bad news could push short interest up to levels where institutions begin to bail.

    With very positive news Synta is easily a Billion $ + entity. How much? Hard to say, but I think 1.5 to 2.0 billion is reasonable. That puts Synta at $25.00/share - for a short time. Once positive news is announced there will be tremendous focus on earnings and/or partnerships. Any negative news then will push the stock back to the $10 - $15 level.

    Synta is positioned now where they probably can't weather any really bad news.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNTA
0.35-0.01(-3.18%)May 31 4:00 PMEDT